Literature DB >> 20228405

ACCORD and Risk-Factor Control in Type 2 Diabetes.

Peter M Nilsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228405     DOI: 10.1056/NEJMe1002498

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.

Authors:  Piers R Blackett; Dharambir K Sanghera
Journal:  J Clin Lipidol       Date:  2012-04-22       Impact factor: 4.766

2.  Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  Michael C d'Emden; Alicia J Jenkins; Liping Li; Diana Zannino; Kristy P Mann; James D Best; Bronwyn G A Stuckey; Kris Park; Juha Saltevo; Anthony C Keech
Journal:  Diabetologia       Date:  2014-08-23       Impact factor: 10.122

3.  The wrong tool for the job: diabetes public health programs and practice guidelines.

Authors:  Urmimala Sarkar; Andrea López; Karen Black; Dean Schillinger
Journal:  Am J Public Health       Date:  2011-08-18       Impact factor: 9.308

Review 4.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

Review 5.  Target blood pressure in diabetes patients with hypertension--what is the accumulated evidence in 2011?

Authors:  Peter M Nilsson
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

6.  Impact of insulin treatment in diabetic macular edema therapy in type 2 diabetes.

Authors:  Simone Matsuda; Tiffany Tam; Rishi P Singh; Peter K Kaiser; Daniel Petkovsek; Maria Teresa Zanella; Justis P Ehlers
Journal:  Can J Diabetes       Date:  2014-10-22       Impact factor: 4.190

Review 7.  Why do young people with chronic kidney disease die early?

Authors:  Shankar Kumar; Richard Bogle; Debasish Banerjee
Journal:  World J Nephrol       Date:  2014-11-06

8.  NOX4 pathway as a source of selective insulin resistance and responsiveness.

Authors:  Xiangdong Wu; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-09       Impact factor: 8.311

Review 9.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

10.  Mexican American trial of community health workers: a randomized controlled trial of a community health worker intervention for Mexican Americans with type 2 diabetes mellitus.

Authors:  Steven K Rothschild; Molly A Martin; Susan M Swider; Carmen M Tumialán Lynas; Imke Janssen; Elizabeth F Avery; Lynda H Powell
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.